首页> 外文会议>AIChE Annual Meeting >Design, optimization, monitoring and control of continuous pharmaceutical manufacturing plant for QbD and PAT based next generation of efficient manufacturing
【24h】

Design, optimization, monitoring and control of continuous pharmaceutical manufacturing plant for QbD and PAT based next generation of efficient manufacturing

机译:QBD的连续制药制造厂的设计,优化,监测和控制,并基于下一代高效制造

获取原文

摘要

A novel manufacturing strategy based on continuous processing integrated with inline/online monitoring tools (PAT) coupled with efficient automatic advanced feedback control system is highly desired for efficient QbD based manufacturing of the next generation of pharmaceutical products with optimal consumption of time, space and resources. However, the particulate systems are still poorly understood and there is different level of complexities involved, therefore to achieve this paradigm shift, new techniques and tools need to be developed through extensive fundamental and applied research. This area of research and education are highly encouraged and supported by pharmaceutical companies, academic institutions, regulatory authority (FDA) and national science foundation (NSF). For example, recently national science foundation of USA has established a 100 million dollar research center for structured organic particulate systems (C-SOPS) at Rutgers University New Jersey. Furthermore, more than 40 companies are supporting this center economically and providing scientific inputs so that the research outcomes can be directly applied to the companies.
机译:基于连续处理的新型制造策略与内联/在线监测工具(PAT)相结合,高效地基于基于QBD的制造的下一代药品的高效制造,具有最佳的时间,空间和资源。然而,颗粒系统仍然明白并且涉及不同程度的复杂性,因此为了实现这种范式偏移,需要通过广泛的基础和应用研究来开发新的技术和工具。该研究和教育领域受到制药公司,学术机构,监管机构(FDA)和国家科学基金会(NSF)的高度鼓励和支持。例如,最近美国国家科学基金会在新泽西州Rutgers大学的结构化有机微粒系统(C-SOP)的建立了1亿美元的研究中心。此外,超过40家公司在经济上支持这一中心,并提供科学投入,以便研究成果可以直接应用于公司。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号